Disease duration, hypertension and medication requirements are associated with organ damage in childhood-onset systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 23, Issue 2, 2005, Pages 261-269

  Lilleby, Vibke ^a   Flatø, Berit ^a   Førre, Øystein ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Children; Outcome assessment; Paediatrics; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; DRUG MEGADOSE; DRUG USE; FACTORIAL ANALYSIS; FEMALE; HEALTH STATUS; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MUSCULOSKELETAL INJURY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; SELF REPORT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; AGE OF ONSET; CROSS-SECTIONAL STUDIES; CYCLOPHOSPHAMIDE; FEMALE; GLUCOCORTICOIDS; HEALTH STATUS; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; LUPUS NEPHRITIS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MUSCULOSKELETAL DISEASES; NORWAY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 18644378857     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. JONSSON H, NIVED O, STURFELT G, SILMAN A: Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. Br J Rheumatol 1990; 29: 185-8.
2. GLIDDEN RS, MANTZOURANIS EC, BOREL Y: Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patients. Clin Immunol Immunopathol 1983; 29: 196-210.
3. LEHMAN TJ: Long-term outcome of systemic lupus erythematosus in childhood. What is the prognosis? Rheum Dis Clin North Am 1991; 17: 921-30.
4. MEISLIN AG, ROTHFIELD N: Systemic lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently. Pediatrics 1968; 42: 37-49.
5. KLEIN-GITELMAN M, REIFF A, SILVERMAN ED: Systemic lupus erythematosus in childhood. Rheum Dis Clin North Am 2002; 28: 561-77.
6. LACKS S, WHITE P: Morbidity associated with childhood systemic lupus erythematosus. J Rheumatol 1990; 17: 941-5.
7. BONGU A, CHANG E, RAMSEY-GOLDMAN R: Can morbidity and mortality of SLE be improved? Best Pract Res Clin Rheumatol 2002; 16: 313-32.
8. CARRENO L, LOPEZ-LONGO FJ, MONTEAGUDO et al.: Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus 1999; 8: 287-92.
9. CERVERA R, KHAMASHTA MA, FONT J et al.: Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993; 72: 113-24.
10. FONT J, CERVERA R, ESPINOSA G et al.: Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998; 57: 456-9.
11. ABELES M, URMAN JD, WEINSTEIN A, LOWENSTEIN M, ROTHFIELD NF: Systemic lupus erythematosus in the younger patient: survival studies. J Rheumatol 1980; 7: 515-22.
12. CAEIRO F, MICHIELSON FM, BERNSTEIN R, HUGHES GR, ANSELL BM: Systemic lupus erythematosus in childhood. Ann Rheum Dis 1981; 40: 325-31.
13. MARINI R, COSTALLAT LT: Young age at onset, renal involvement, and arterial hypertension are of adverse prognostic significance in juvenile systemic lupus erythematosus. Rev Rhum Engl Ed 1999; 66: 303-9.
14. TUCKER LB, MENON S, SCHALLER JG, ISENBERG DA: Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995; 34: 866-72.
15. GLADMAN D, GINZLER E, GOLDSMITH C et al.: The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-9.
16. STOLL T, SEIFERT B, ISENBERG DA: SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996; 35: 248-54.
17. BRUNNER HI, SILVERMAN ED, TO T, BOMBARDIER C, FELDMAN BM: Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002; 46: 436-44.
18. RAVELLI A, DUARTE-SALAZAR C, BURATTI S et al.: Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 2003; 49: 501-7.
19. ROOD MJ, TEN CATE R, SUIJLEKOM-SMIT LW et al.: Childhood-onset systemic lupus erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol 1999; 28: 222-6.
20. Statistical Yearbook of Norway. Oslo, Statistisk sentralbyrå, 2003.
21. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
22. BOMBARDIER C, GLADMAN DD, UROWITZ MB, CARON D, CHANG CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-40.
23. RUPERTO N, RAVELLI A, MURRAY KJ et al.: Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003; 42: 1452-9.
24. BRUNNER HI, FELDMAN BM, BOMBARDIER C, SILVERMAN ED: Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1999; 42: 1354-60.
25. GLADMAN DD, UROWITZ MB, GOLDSMITH CH et al.: The reliability of the Systemic Lupus International Collaborating Clinics/ American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 809-13.
26. TANNER JM: Normal growth and techniques of growth assessment. Clin Endocrinol Metab 1986; 15: 411-51.
27. HUBER AM, LANG B, LeBLANC CM et al.: Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000; 43: 541-9.
28. KNUDTZON J, AARSKOG D: Skjelettalder og prediksjon av slutthøyde. Pediatrisk endokrinologi 1988; 2: 69-71.
29. FLATO B, SORSKAAR D, VINJE O et al.: Measuring disability in early juvenile rheumatoid arthritis: evaluation of a Norwegian version of the childhood Health Assessment Questionnaire. J Rheumatol 1998; 25: 1851-8.
30. MILLIGAN SE, HOM DL, BALLOU SP, PERSSE LJ, SVILAR GM, COULTON CJ: An assessment of the Health Assessment Questionnaire functional ability index among women with systemic lupus erythematosus. J Rheumatol 1993; 20: 972-6.
31. SINGH G, ATHREYA BH, FRIES JF, GOLDSMITH DP: Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994; 37: 1761-9.
32. DUFFY CM, DUFFY KN: Health assessment in the rheumatic diseases of childhood. Curr Opin Rheumatol 1997; 9: 440-7.
33. WARE JE Jr, SHERBOURNE CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
34. KVIEN TK, KAASA S, SMEDSTAD LM: Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 1998; 51: 1077-86.
35. STOLL T, GORDON C, SEIFERT B et al.: Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 1608-14.
36. ALTMAN DG: Relation between several variables. In ALTMAN DG: Practical Statistics for Medical Research. London, Chapman & Hall, 1997: 325-61.
37. PETRI M: Hopkins Lupus Cohort. 1999 update. Rheum Dis Clin North Am 2000; 26: 199-213.
38. MIETTUNEN PM, ORTIZ-ALVAREZ O, PETTY RE et al.: Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus. J Rheumatol 2004; 31: 1650-4.
39. HAGELBERG S, LEE Y, BARGMAN J et al.: Longterm followup of childhood lupus nephritis. J Rheumatol 2002; 29: 2635-42.
40. REVEILLE JD, BARTOLUCCI A, ALARCON GS: Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990; 33: 37-48.
41. URIBE AG, ALARCON GS: Ethnic disparities in patients with systemic lupus erythematosus. Curr Rheumatol Rep 2003; 5: 364-9.
42. PETRI M, PEREZ-GUTTHANN S, LONGE-NECKER JC, HOCHBERG M: Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 1991; 91: 345-53.
43. SUTCLIFFE N, CLARKE AE, GORDON C, FAREWELL V, ISENBERG DA: The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford) 1999; 38: 1130-7.
44. ZONANA-NACACH A, BARR SG, MAGDER LS, PETRI M: Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 2000; 43: 1801-8.
45. GLADMAN DD, UROWITZ MB, RAHMAN P, IBANEZ D, TAM LS: Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 2003; 30: 1955-9.
46. DAYAL NA, GORDON C, TUCKER L, ISENBERG DA: The SLICC damage index: past, present and future. Lupus 2002; 11: 261-5.
47. KARLSON EW, DALTROY LH, LEW RA et al.: The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 47-56.
48. RIVEST C, LEW RA, WELSING PM et al.: Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 2000; 27: 680-4.
49. BLANCO FJ, GOMEZ-REINO JJ, de la MATA J et al.: Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus 1998; 7: 159-63.
50. WARD MM, PYUN E, STUDENSKI S: Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 1995; 38: 274-83.